Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115764) titled 'Correlation between NUCB2/nesfatin-1 and Bone Health in Middle-aged and Elderly Women' on Dec. 31, 2025.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Hangzhou Women's Hospital
Condition:
Postmenopausal osteoporosis
Intervention:
abnormal bone mass group:none
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-01
Target Sample Size: abnormal bone mass group:300;normal bone mass group:500;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=303320
Disclaimer: Curated by HT Syndication....